➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
Colorcon
Baxter
AstraZeneca

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

DYCILL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Dycill patents expire, and what generic alternatives are available?

Dycill is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in DYCILL is dicloxacillin sodium. There are nine drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.

Summary for DYCILL
Drug patent expirations by year for DYCILL
Synonyms for DYCILL
13412-64-1
3-(2,6-Dichlorophenyl)-5-methyl-4-isoxazolyl penicillin sodium monohydrate
3116-76-5 (non-salt)
343-55-5 (anhydrous)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate, (2S,5R,6R)-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-, monosodium salt, monohydrate
4HZT2V9KX0
AC-18976
AKOS015962897
Bayer 5488
BCP28581
BDBM50005106
Biocloxin
BLP-1011
Brispen
BRL-1702
C13756
C19H16Cl2N3NaO5S.H2O
CAS-13412-64-1
CCG-220450
CHEBI:52019
CHEMBL1200701
Ciclex
Clocil
Constaphyl
CS-4467
D02137
Dichlorstapenor sodium
Diclocil
Dicloxacillin (Sodium hydrate)
Dicloxacillin sodium
Dicloxacillin sodium (USP)
Dicloxacillin sodium [USAN:BAN:JAN]
Dicloxacillin sodium [USAN:USP:BAN:JAN]
Dicloxacillin sodium hydrate
Dicloxacillin sodium hydrate (JP17)
DICLOXACILLIN SODIUM MONOHYDRATE
Dicloxacillin sodium salt hydrate
Dicloxacillin sodium salt hydrate, VETRANAL(TM), analytical standard
Dicloxacillin sodium salt monohydrate
Dicloxacillin sodium, European Pharmacopoeia (EP) Reference Standard
Dicloxacillin sodium, United States Pharmacopeia (USP) Reference Standard
Diflor
Digloxilline
DSSTox_CID_28928
DSSTox_GSID_49002
DSSTox_RID_83194
DTXSID2049002
Dycill (TN)
Dynapen
FT-0602594
HMS2096I22
HMS2234C13
HMS3713I22
HY-B0977
LS-149774
M270
MDI-PC
MFCD00167147
MLS001332403
MLS001332404
MLS002153818
Monosodium (2S,5R,6R)-6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate
Monosodium (2S,5R,6R)-6-[3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo [3.2.0]heptane-2-carboxylate monohydrate
NCGC00178782-02
NCGC00178782-04
NCGC00180956-01
Novapen
Noxaben
P 1011
P-1011
Pathocil
Pen-Sint
Q27887689
R 13423
s4111
SCHEMBL41515
SIGZQNJITOWQEF-VICXVTCVSA-M
SMR000875239
sodium (2S,5R,6R)-6-({[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate
sodium (2S,5R,6R)-6-(3-(2,6-dichlorophenyl)-5-methylisoxazole-4-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate
sodium 6beta-{[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazol-4-yl]carboxamido}-2,2-dimethylpenam-3alpha-carboxylate--water (1/1)
Sodium dicloxacillin hydrate
Sodium dicloxacillin monohydrate
sodium;(2S,5R,6R)-6-[[3-(2,6-dichlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate;hydrate
Stampen
Staphcillin A banyu
Tox21_113495
Tox21_113495_1
UNII-4HZT2V9KX0

US Patents and Regulatory Information for DYCILL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 060254-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 062238-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline DYCILL dicloxacillin sodium CAPSULE;ORAL 062238-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
Express Scripts
Colorcon
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.